Begin with the outcome
Tell the provider whether your priority is recovery, body composition, skin support, cognitive wellness, longevity or sexual wellness.
Visit our appointment-only El Segundo clinic for provider-guided peptide consultations serving Manhattan Beach, Hermosa Beach, Westchester, Playa Vista, Hawthorne and the LAX area. Your medical team confirms candidacy, formulation and current pharmacy availability before any treatment is prescribed.
Prescription required. Many peptide uses are investigational or off-label. Availability can change with federal/state rules and pharmacy sourcing.

The prices below cover each complete listed cycle at our El Segundo location. If the medical team approves your program and you continue the prescribed plan, the same event price remains available for future cycles. There is no need to select a peptide before your consultation.
Provider-directed rest periods preserve your rate. If you voluntarily stop or allow the program to lapse, the price available when you restart will apply.
Medical eligibility, prescription, current formulation and pharmacy availability are confirmed before treatment.This location page helps you compare complete-cycle options before meeting the El Segundo medical team. The appointment begins with what you want to address, then moves to evidence, candidacy and current availability. For broader compound-by-compound education, visit our complete peptide therapy guide.
Tell the provider whether your priority is recovery, body composition, skin support, cognitive wellness, longevity or sexual wellness.
Each card shows the vial quantity, cycle length, all-inclusive regular price and Labor Day price so the commitment is easier to understand.
Your appointment at 425 Main Street includes health-history and medication review before any prescription is considered.
If treatment is approved, the El Segundo team provides administration guidance, follow-up and reassessment throughout the active plan.
The online menu is a planning tool, not a guarantee that every compound can be prescribed. Many wellness peptides are investigational, and compounded medications are not FDA-approved drugs.
The provider reviews whether the requested compound has a reasonable role for your goal, whether a lawful pharmacy pathway is currently available and whether the formulation is appropriate. Tesamorelin and bremelanotide have branded FDA approvals for narrow indications, not unrestricted wellness use.

Compare the combined Wolverine protocol with individual BPC-157 and TB-500-related options. The consultation determines whether any recovery-focused program is appropriate.
For patients comparing a combined recovery protocol with single-compound options. This clinic-defined blend is investigational for wellness use and requires provider review before prescription.
Discuss this program →A single-compound recovery-oriented plan with an eight-week schedule. BPC-157 is investigational, is not FDA-approved and may be prescribed only after individualized review.
Discuss this program →A separate eight-week recovery option using a TB-500-related peptide. It is investigational, not FDA-approved and considered only after the provider reviews the intended goal.
Discuss this program →
These are different compounds with different cycle lengths, clinical considerations and regulatory status. They should be compared with a provider, not treated as interchangeable.
This twelve-week combination acts on the growth-hormone axis and is considered for selected goals. Neither compound is FDA-approved for broad anti-aging or body-composition claims.
Discuss this program →An eight-week tesamorelin plan that requires indication-specific medical review. The approved branded indication concerns HIV-associated lipodystrophy, not general weight loss.
Discuss this program →A twelve-week investigational program discussed in relation to fat-metabolism goals. AOD-9604 is not FDA-approved, and the provider determines whether it has a reasonable clinical role.
Discuss this program →The longest program in this category, with a sixteen-week schedule and six vials. Clinical rationale, formulation and pharmacy availability are confirmed before prescribing.
Discuss this program →
GLOW70 combines three components in a shorter cycle, while the GHK-Cu plan uses a longer three-vial protocol. Formulation and candidacy are confirmed locally.
A shorter four-week Skin Works blend for patients comparing multi-component skin-support options. Its ingredients have different evidence and regulatory profiles.
Discuss this program →A longer twelve-week GHK-Cu plan using three 100mg vials. Injectable and topical formulations have different regulatory considerations, so the exact formulation is confirmed first.
Discuss this program →
Review Semax, Selank or the combined Clarity Stack by goal and full-cycle commitment. All three options remain investigational in the United States.
An eight-week, two-stage plan discussed in relation to cognitive goals. Semax is investigational in the United States, and cognition-related claims remain unapproved.
Discuss this program →An eight-week, two-stage option discussed in relation to mood and stress goals. Selank is not FDA-approved and is not a replacement for approved mood or anxiety treatment.
Discuss this program →A combined Semax and Selank protocol for patients comparing the two single-compound plans with one stack. Both components remain investigational in the United States.
Discuss this program →
This category spans four- to twelve-week programs with very different ingredients and research backgrounds. The provider helps separate marketing language from the available evidence.
A twelve-week Skin Works blend combining GLOW70 with KPV. Its components are investigational for these wellness uses, so candidacy and current availability must be confirmed.
Discuss this program →A six-week mitochondrial-derived peptide program considered for selected metabolic goals. MOTS-c remains investigational and is not FDA-approved for metabolic optimization or longevity.
Discuss this program →A four-week, one-vial option associated with longevity research. Epitalon is not FDA-approved, and claims involving telomeres or lifespan remain unproven.
Discuss this program →A four-week, one-vial plan discussed in relation to immune-support goals. Thymosin alpha-1 is not an FDA-approved drug in the United States.
Discuss this program →
This one-vial, on-demand protocol is reviewed separately from the recurring peptide cycles. Vyleesi approval is indication-specific, and other use is outside its label.
A one-vial, on-demand option reviewed separately from recurring peptide cycles. FDA-approved Vyleesi has a narrow indication; other use is outside that labeled indication.
Discuss this program →Your Main Street visit turns a general goal into a specific medical decision, with the complete cycle and protected event price explained before treatment.
Meet with the medical team at 425 Main Street and discuss the outcome you are trying to achieve rather than choosing a peptide from a menu alone.
Your provider reviews health history, medications, contraindications, evidence, formulation options and whether the requested compound is currently appropriate and available.
If treatment is prescribed, the team confirms the exact cycle, pharmacy source, administration instructions and protected Labor Day price.
Response, tolerance and ongoing appropriateness are reassessed. The plan can be continued, changed or stopped based on clinical judgment.
These answers cover location access, scheduling, pricing and medical review for peptide consultations in El Segundo.
Appointments take place at Skin Works Medical Spa, 425 Main Street, El Segundo, CA 90245. This location operates by appointment only.
Yes. The Main Street location is convenient for Manhattan Beach, Hermosa Beach, Westchester, Hawthorne, Playa Vista, Marina del Rey and communities around LAX.
Yes. The Labor Day and regular full-cycle prices are aligned across Skin Works locations. This page uses a different local consultation experience and booking path, but the listed protocols and prices remain consistent.
No. Tell the El Segundo team what you would like to address. The provider will review whether a peptide program has a reasonable clinical role and which option, if any, is appropriate.
Yes. Prescription peptide programs require a medical evaluation and an appropriate prescription. The El Segundo consultation also confirms current formulation and pharmacy availability.
No. Many listed compounds are investigational and are not FDA-approved drugs. Tesamorelin and bremelanotide have approved branded products for narrow indications, which does not make every compounded formulation or other use FDA-approved.
Begin an approved program at the event price and continue the prescribed plan. Provider-directed rest periods preserve the rate. If you voluntarily stop or allow the plan to lapse, the price available when you restart will apply.
Use the El Segundo booking link to view current availability, call (424) 321-4517 or text (844) 759-6757 for help scheduling your consultation.
Appointment-only peptide consultations at 425 Main Street, convenient for Manhattan Beach, Hermosa Beach, Westchester, Hawthorne, Playa Vista, Marina del Rey and the LAX area.
Visit the Skin Works medical team on Main Street, explain what you want to address and receive a clear answer about candidacy, available options, complete-cycle pricing and whether peptide therapy belongs in your plan.
Medical disclaimer: This page is informational and does not constitute medical advice or a prescription. Program availability, formulation, price and pharmacy sourcing may change. Many peptide compounds and wellness uses described on the market are not FDA-approved. Compounded drugs are not reviewed by FDA for safety, effectiveness or quality before marketing in the same way as FDA-approved drugs. Promotional pricing requires medical approval and applies while the prescribed treatment plan remains active. Provider-directed rest periods do not interrupt rate protection. If a patient stops or allows the program to lapse, the price available at restart applies.